A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity.
暂无分享,去创建一个
I. Lukashevich | R. Carrion | J. Patterson | G. Hubbard | M. Salvato | K. Brasky | J. Zapata | Curtis Johnson | M. Gonzales | Carmen R Moreira | Anysha E Ticer | D. Moshkoff
[1] I. Lukashevich,et al. Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses , 2007, Virus Genes.
[2] Barbara S. Stewart,et al. Identification of Protective Lassa Virus Epitopes That Are Restricted by HLA-A2 , 2006, Journal of Virology.
[3] Igor S. Lukashevich and Maria S. Salvato. Lassa Virus Genome , 2006 .
[4] R. Charrel,et al. Phylogeny and evolution of old world arenaviruses. , 2006, Virology.
[5] M. Wolfe,et al. Historical Lassa Fever Reports and 30-year Clinical Update , 2006, Emerging infectious diseases.
[6] L. Fernando,et al. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment , 2006, The Lancet.
[7] M. Puig,et al. CpG Oligodeoxynucleotides Protect Newborn Mice from a Lethal Challenge with the Neurotropic Tacaribe Arenavirus , 2006, The Journal of Immunology.
[8] M. Georges-Courbot,et al. Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. , 2006, Microbes and infection.
[9] V. Deubel,et al. A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. , 2006, Virology.
[10] D. Hassett,et al. Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8 T cell-mediated, TNF-dependent immunopathology. , 2006, The Journal of clinical investigation.
[11] P. Darlu,et al. Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate. , 2006, The Journal of general virology.
[12] I. Lukashevich,et al. A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses , 2005, Journal of Virology.
[13] K. Sundar,et al. Lassa Fever Virus Peptides Predicted by Computational Analysis Induce Epitope-Specific Cytotoxic-T-Lymphocyte Responses in HLA-A2.1 Transgenic Mice , 2005, Clinical Diagnostic Laboratory Immunology.
[14] M. Buchmeier,et al. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein. , 2005, Virology.
[15] S. Spector,et al. Yellow fever vaccine , 1972, Archiv für die gesamte Virusforschung.
[16] Update on Lassa fever in West Africa. , 2005, Releve epidemiologique hebdomadaire.
[17] I. Lukashevich,et al. Ribonucleic acids of Machupo and Lassa viruses , 2005, Archives of Virology.
[18] I. Lukashevich,et al. Some biochemical properties of Lassa virus RNA and polypeptides , 1986, Medical Microbiology and Immunology.
[19] M. Georges-Courbot,et al. Human Macrophages, but Not Dendritic Cells, Are Activated and Produce Alpha/Beta Interferons in Response to Mopeia Virus Infection , 2004, Journal of Virology.
[20] R. Hewson,et al. Evidence of segment reassortment in Crimean-Congo haemorrhagic fever virus. , 2004, The Journal of general virology.
[21] Lassa fever: epidemiology, clinical features, and social consequences , 2004, BMJ : British Medical Journal.
[22] I. Lukashevich,et al. LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration , 2004, Archives of Virology.
[23] A. Barrett,et al. Ngari Virus Is a Bunyamwera Virus Reassortant That Can Be Associated with Large Outbreaks of Hemorrhagic Fever in Africa , 2004, Journal of Virology.
[24] J. McCormick,et al. Lassa fever vaccine , 2004, Expert review of vaccines.
[25] A. Hoerauf,et al. Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. , 2004, Virology.
[26] S. Günther,et al. Inhibition of Different Lassa Virus Strains by Alpha and Gamma Interferons and Comparison with a Less Pathogenic Arenavirus , 2004, Journal of Virology.
[27] M. Georges-Courbot,et al. Lassa Virus Infection of Human Dendritic Cells and Macrophages Is Productive but Fails to Activate Cells1 , 2004, The Journal of Immunology.
[28] Heinz Feldmann,et al. New insights into the evolutionary relationships between arenaviruses provided by comparative analysis of small and large segment sequences. , 2003, Virology.
[29] R. Ahmed,et al. Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection. , 2003, Virology.
[30] Persephone Borrow,et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers , 2003, Nature.
[31] R. Rico-Hesse,et al. High genetic divergence and recombination in Arenaviruses from the Americas. , 2002, Virology.
[32] Philip K. Russell,et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. , 2002, JAMA.
[33] J. Clegg,et al. Molecular phylogeny of the arenaviruses. , 2002, Current topics in microbiology and immunology.
[34] P. Jahrling,et al. Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses , 2001, Journal of Virology.
[35] L. Zhang,et al. Reassortant analysis of guinea pig virulence of pichinde virus variants. , 2001, Virology.
[36] N. Seidah,et al. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. McCormick,et al. Towards a human Lassa fever vaccine , 2001, Reviews in medical virology.
[38] G. Neumann,et al. Ebola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer , 2001, Journal of Virology.
[39] M. Bray. The role of the Type I interferon response in the resistance of mice to filovirus infection. , 2001, The Journal of general virology.
[40] I. Lukashevich,et al. Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus. , 2001, Journal of human virology.
[41] S. Günther,et al. Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. , 2000, Emerging infectious diseases.
[42] Stuart T. Nichol,et al. Genetic Diversity among Lassa Virus Strains , 2000, Journal of Virology.
[43] L. Hutwagner,et al. Effective Vaccine for Lassa Fever , 2000, Journal of Virology.
[44] R. Welsh,et al. Bystander Sensitization to Activation-Induced Cell Death as a Mechanism of Virus-Induced Immune Suppression , 2000, Journal of Virology.
[45] A. Hoerauf,et al. Characterization of Human CD4+ T-Cell Clones Recognizing Conserved and Variable Epitopes of the Lassa Virus Nucleoprotein , 2000, Journal of Virology.
[46] L. Xia,et al. Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein. , 2000, Vaccine.
[47] I. Lukashevich,et al. Lassa and mopeia virus replication in human monocytes/macrophages and in endothelial cells: Different effects on IL‐8 and TNF‐α gene expression , 1999, Journal of medical virology.
[48] P. Zanotto,et al. Genetic Reassortment of Rift Valley Fever Virus in Nature , 1999, Journal of Virology.
[49] C. Peters,et al. Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. , 1997, Molecular phylogenetics and evolution.
[50] I. Lukashevich,et al. Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. , 1997, Virology.
[51] M. Sabattini,et al. Characterization of arenaviruses using a family-specific primer set for RT-PCR amplification and RFLP analysis. Its potential use for detection of uncharacterized arenaviruses. , 1997, Virus research.
[52] I. Lukashevich,et al. The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum. , 1997, The Journal of general virology.
[53] R. Zinkernagel,et al. Virus-induced Transient Bone Marrow Aplasia: Major Role of Interferon-α/β during Acute Infection with the Noncytopathic Lymphocytic Choriomeningitis Virus , 1997, The Journal of experimental medicine.
[54] J. Chang-Claude,et al. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. , 1996, The American journal of tropical medicine and hygiene.
[55] P. Borrow,et al. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression , 1995, Journal of virology.
[56] D. Brown,et al. Early diagnosis of Lassa fever by reverse transcription-PCR , 1994, Journal of clinical microbiology.
[57] R. Zinkernagel,et al. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon , 1994, Journal of virology.
[58] I. Lukashevich,et al. Lassa virus activity in Guinea: Distribution of human antiviral antibody defined using enzyme‐linked immunosorbent assay with recombinant antigen , 1993, Journal of medical virology.
[59] G. Cole,et al. Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus , 1993, Journal of virology.
[60] I. Lukashevich. Generation of reassortants between African arenaviruses. , 1992, Virology.
[61] J. McCormick,et al. Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys , 1992, Journal of medical virology.
[62] R. Zinkernagel,et al. Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide , 1991, European journal of immunology.
[63] S. Wilson,et al. Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products. , 1991, Virus research.
[64] I. Lukashevich,et al. Prediction of arenavirus fusion peptides on the basis of computer analysis of envelope protein sequences , 1990, FEBS letters.
[65] J. Saluzzo,et al. Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. , 1990, Vaccine.
[66] A. Zuckerman. Vaccines, cells, and nucleic acids: Workshop on vaccines prepared in continuous mammalian cell lines and by recombinant systems , 1990 .
[67] J. Whitton,et al. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity , 1989, Journal of virology.
[68] G. Lloyd,et al. VACCINIA RECOMBINANT EXPRESSING LASSA-VIRUS INTERNAL NUCLEOCAPSID PROTEIN PROTECTS GUINEAPIGS AGAINST LASSA FEVER , 1987, The Lancet.
[69] P. Jahrling,et al. Experimental studies of arenaviral hemorrhagic fevers. , 1987, Current topics in microbiology and immunology.
[70] J. McCormick,et al. Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. , 1986, Virology.
[71] J. McCormick,et al. Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.
[72] Lukashevich Is,et al. Sedimentation analysis of the RNAs isolated from interfering particles of Lassa and Machupo viruses. , 1985 .
[73] M. Buchmeier,et al. Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment , 1985, Journal of virology.
[74] I. Lukashevich,et al. Sedimentation analysis of the RNAs isolated from interfering particles of Lassa and Machupo viruses. , 1985, Acta virologica.
[75] P. Jahrling,et al. Pathogenesis of Lassa virus infection in guinea pigs , 1982, Infection and immunity.
[76] A. Anusz. [Lassa fever]. , 1981, Pielegniarka i polozna.
[77] Sabattini Ms,et al. Activity of lymphocytic choriomeningitis virus (LCM) in the endemic area of Argentine hemorrhagic fever (AHF). I. Serological studies in rodents captured in the City of Pergamino , 1972 .
[78] J. Maiztegui,et al. [Activity of lymphocytic choriomeningitis virus (LCM) in the endemic area of Argentine hemorrhagic fever (AHF). I. Serological studies in rodents captured in the City of Pergamino]. , 1972, Medicina.
[79] J. Hotchin. The biology of lymphocytic choriomeningitis infection: virus-induced immune disease. , 1962, Cold Spring Harbor symposia on quantitative biology.